The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Eosinophilic pneumonia (pulmonary infiltrates and eosinophilia)
Imaging features e.g.: PMID : 23996619
Publications
[Eosinophilic pneumonia toxicity induced by Dapsone].
RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin 2014 Feb;186;178-9 — 2014 Feb — 178-9
Dapsone induced eosinophilic pneumonia.
European annals of allergy and clinical immunology 2012 Jun;44;144-6 — 2012 Jun — 144-6
Dapsone-induced eosinophilic pneumonitis in a leprosy patient.
Indian journal of leprosy 2005 Jul-Sep;77;267-71 — 2005 Jul-Sep — 267-71
Dapsone induced pulmonary eosinophilia without cutaneous allergic manifestations--an unusual encounter--a case report.
Acta leprologica 1998;11;3-5 — 1998 — 3-5
Eosinophilic pneumonia induced by dapsone.
BMJ (Clinical research ed.) 1998 Jul 18;317;181 — 1998 Jul 18 — 181
Pulmonary eosinophilia associated with dapsone.
Lancet (London, England) 1994 Apr 02;343;860-1 — 1994 Apr 02 — 860-1